Abstract: A mold element, in particular a casting mold for manufacturing microstructures, in particular microneedle arrays, includes a base body. On an upper side of the base body, several depressions for receiving material for manufacturing the microstructure are provided. In order to improve the quality of the microstructure to be manufactured, in particular during a drying process, channels are provided on the upper side of the base body, each of which is connected to at least one of the depressions.

Abstract: The invention relates to a microneedle array, in particular to an applicator system, and to the use thereof for the intradermal delivery of active ingredients in the form of salts, in particular medicinal drugs in the form of salts, wherein this microneedle array is suitable for penetrating the skin of humans or animals, and the microneedles are made of a formulation, containing at least one active ingredient in the form of a salt and at least one biodegradable polymer.

Abstract: The invention provides agents and methods for treating bacterial infections using RNA. The RNA encoding peptidoglycan hydrolases. e.g., endolysins, is formulated and administered in a way that peptidoglycan hydrolase proteins. e.g., endolysin proteins, can be produced and secreted by cells of a subject to combat bacterial infections.

Abstract: The present invention relates to a microneedle system (MNS for short) for the intradermal application of a hepatitis vaccine, namely the antigen HBsAg.

Abstract: The present invention relates to a microneedle system (MNS) for intradermal application in a controlled release of glucagon-like peptide analogues.

Abstract: A mold element, in particular a casting mold for manufacturing microstructures, in particular microneedle arrays, includes a base body. On an upper side of the base body, several depressions for receiving material for manufacturing the microstructure are provided. In order to improve the quality of the microstructure to be manufactured, in particular during a drying process, channels are provided on the upper side of the base body, each of which is connected to at least one of the depressions.

Abstract: The present invention relates to a microneedle system (MNS) for the intradermal delivery of interferon, wherein polyvinylpyrrolidone is the major constituent of a completely soluble formulation.

Abstract: The present invention relates to a microneedle system (MNS) for the intradermal delivery of interferon, wherein polyvinylpyrrolidone is the major constituent of a completely soluble formulation.

Abstract: A carrier element for micro-needles for forming a micro-needle array has a plate-like base element. Mounting elements for respectively connecting to a micro-needle of the micro-needle array are provided on a front side of the base element. Connecting elements are also provided, in particular on the front side of the mounting elements. The connecting elements are formed in such a way that they have an undercut in the longitudinal direction such that the needles are reliably connected to the mounting elements.

Abstract: The invention relates to a microneedle array and to the use thereof for intradermal delivery, comprising a plurality of microneedles on a carrier, wherein this microneedle array is suitable for penetrating the skin of humans or animals and includes at least one color change indicator.

Abstract: The invention relates to a microneedle array and to the use thereof for intradermal delivery, comprising a plurality of microneedles on a carrier, wherein this microneedle array is suitable for penetrating the skin of humans or animals and includes at least one color change indicator.

Abstract: The present invention relates to a microneedle system (MNS for short) for the intradermal application of a hepatitis vaccine, namely the antigen HBsAg.

Abstract: The present invention relates to a microneedle system (MNS) for the intradermal delivery of interferon, wherein polyvinylpyrrolidone is the major constituent of a completely soluble formulation.

Abstract: The invention relates to a microneedle array, in particular to an applicator system, and to the use thereof for the intradermal delivery of active ingredients in the form of salts, in particular medicinal drugs in the form of salts, wherein this microneedle array is suitable for penetrating the skin of humans or animals, and the microneedles are made of a formulation, containing at least one active ingredient in the form of a salt and at least one biodegradable polymer.

Abstract: The invention relates to a connector for connecting a first solar cell electrode to a further element, wherein the connector has a metallic conductor structure and the conductor structure is coated along the periphery thereof alternately in a circumferential manner with two respective continuous areas of materials A and B, wherein A is a solder material and B is a dielectric material, characterized in that the surface area of each orthogonal projection of the entire connector is at least 10% larger than the surface area of the orthogonal projection of each of the areas of material A. The invention further relates to a method for producing the connector and to a photovoltaic component containing the connector according to the invention.

Abstract: The invention relates to a microneedle array and to the use thereof for intradermal delivery, comprising a plurality of microneedles on a carrier, wherein this microneedle array is suitable for penetrating the skin of humans or animals and includes at least one color change indicator.

Abstract: The present invention relates to a microneedle system (MNS) for intradermal application in a controlled release of glucagon-like peptide analogues.

Abstract: The present invention relates to a connector for connecting a solar cell electrode to a further element, whereby the connector comprises a conductor pattern on which at least one metallic coating is arranged, whereby the conductor pattern contains aluminium, characterised in that the coating contains an element selected from the group consisting of Ni, Ag, Sn, Pb, Zn, Bi, In, Sb, Co, Cr as well as alloys of said elements.

Abstract: The invention relates to the needle-free subcutaneous administration of proteins to humans and animals by means of a protein delivery device comprising a unit made of a nozzle, a chamber, a piston, an actuating device, and a drive, and a corresponding process and its use.